Study Stopped
Proof of principle was achieved after inclusion of 7 patients
Self-Propelled Percutaneous Endoscopic GastroJejunostomy (PEG-J)
1 other identifier
interventional
7
1 country
1
Brief Summary
This research is being done to study the safety of an investigational percutaneous endoscopic gastrojejunostomy (PEGJ) tube and whether the addition of a balloon on the end of the J tube prevents it from slipping back into the stomach.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_2
Started Jan 2012
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 29, 2012
CompletedFirst Posted
Study publicly available on registry
March 12, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2012
CompletedResults Posted
Study results publicly available
October 12, 2016
CompletedMarch 31, 2017
March 1, 2017
4 months
February 29, 2012
August 21, 2016
March 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safety: Number of Participants With Adverse Events
One week after the procedure patients were called by one of the study investigators and were asked whether or not they had Abdominal pain, Nausea or Vomiting after the procedure.
From date of PEGJ placement up to 3 weeks
Secondary Outcomes (1)
Number of Participants With Retrograde Migration of PEGJ Feeding Tube Within 3 Weeks of Placement
From date of PEGJ placement up to 3 weeks
Study Arms (1)
PEGJ
EXPERIMENTALPatients in this arm will receive self-propelled balloon PEGJ tube.
Interventions
Eligibility Criteria
You may qualify if:
- age 18-90 years
- need for post-pyloric feeding (patients unable to eat due to stroke, intubated patients with respiratory failure, patients with acute pancreatitis, etc)
- ability to give informed consent for the study
You may not qualify if:
- patients with uncorrectable bleeding disorders (INR more than 1.5, platelet count less than 50,000)
- inability to get informed consent for the study from patients or their families
- pregnancy (all women of child-bearing age will undergo urine pregnancy testing)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johns Hopkins Universitylead
- GI Supplycollaborator
Study Sites (1)
Johns Hopkins Hospital
Baltimore, Maryland, 21205, United States
Related Publications (1)
Kim KJ, Victor D, Stein E, Valeshabad AK, Saxena P, Singh VK, Lennon AM, Clarke JO, Khashab MA. A novel ballooned-tip percutaneous endoscopic gastrojejunostomy tube: a pilot study. Gastrointest Endosc. 2013 Jul;78(1):154-7. doi: 10.1016/j.gie.2013.03.005. Epub 2013 Apr 24.
PMID: 23622977DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Small number of patients and short follow-up
Results Point of Contact
- Title
- Mouen Khashab
- Organization
- Johns Hopkins University
Study Officials
- PRINCIPAL INVESTIGATOR
Mouen Khashab, MD
Johns Hopkins Hospital Department of Gastroenterology
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine; Director of Therapeutic Endoscopy
Study Record Dates
First Submitted
February 29, 2012
First Posted
March 12, 2012
Study Start
January 1, 2012
Primary Completion
May 1, 2012
Study Completion
May 1, 2012
Last Updated
March 31, 2017
Results First Posted
October 12, 2016
Record last verified: 2017-03